Nurexone Biologic Inc. leads the charge in developing cutting-edge exosome-based therapies for central nervous system injuries, particularly traumatic spinal cord injuries (tSCI), promising groundbreaking...
Vistagen (Nasdaq: VTGN) is a San Francisco-based biopharmaceutical company pioneering neuroscience. Its treatments deliver ground-breaking therapies for individuals affected by psychiatric and neurological disorders. Recently,...
● Leading the charge in exosome-based medicine, NurExone pioneers ExoTherapy, utilizing tiny cell-secreted particles to deliver treatments like ExoPTEN, focusing on spinal cord injury recovery — a...
NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone") is a pioneering biopharmaceutical company developing regenerative medicine therapies. As you can see...
NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) is a leading developer of needle-free devices to administer therapeutics subcutaneously.
No more needle phobia.
NGMD’s...